CYP3A7 | Cytochrome P450, family 3, subfamily A, polypeptide 7 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F11 | Cytochrome P450, family 4, subfamily F, polypeptide 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DNAJC22 | DnaJ (Hsp40) homolog, subfamily C, member 22 | Predicted membrane proteins
| | | | | Tissue enhanced |
ELFN1 | Extracellular leucine-rich repeat and fibronectin type III domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
EPO | Erythropoietin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ERRFI1 | ERBB receptor feedback inhibitor 1 | | | | | | Tissue enhanced |
ETNK2 | Ethanolamine kinase 2 | Enzymes
| | | | | Tissue enhanced |
EVA1A | Eva-1 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Tissue enhanced |
F10 | Coagulation factor X | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F5 | Coagulation factor V (proaccelerin, labile factor) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FBP1 | Fructose-1,6-bisphosphatase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
FMO4 | Flavin containing monooxygenase 4 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
FMO5 | Flavin containing monooxygenase 5 | Cancer-related genes Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FST | Follistatin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FUOM | Fucose mutarotase | Enzymes
| | | | | Tissue enhanced |
G6PC | Glucose-6-phosphatase, catalytic subunit | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GAS2 | Growth arrest-specific 2 | | | | | | Tissue enhanced |
GCH1 | GTP cyclohydrolase 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
GJB1 | Gap junction protein, beta 1, 32kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GPLD1 | Glycosylphosphatidylinositol specific phospholipase D1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GPT | Glutamic-pyruvate transaminase (alanine aminotransferase) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GRB14 | Growth factor receptor-bound protein 14 | | | | | | Tissue enhanced |
GSTA1 | Glutathione S-transferase alpha 1 | Enzymes Plasma proteins
| | | | | Tissue enhanced |
GSTA2 | Glutathione S-transferase alpha 2 | Enzymes
| | | | | Tissue enhanced |
HGD | Homogentisate 1,2-dioxygenase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HNF4A | Hepatocyte nuclear factor 4, alpha | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
HOGA1 | 4-hydroxy-2-oxoglutarate aldolase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enhanced |
HPN | Hepsin | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
HS3ST3B1 | Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 | Enzymes
| | | | | Tissue enhanced |
HYAL1 | Hyaluronoglucosaminidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
IL1RAP | Interleukin 1 receptor accessory protein | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KCNN2 | Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
KLB | Klotho beta | Predicted membrane proteins
| | | | | Tissue enhanced |
KMO | Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
LBX2 | Ladybird homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
LEPR | Leptin receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LGSN | Lengsin, lens protein with glutamine synthetase domain | | | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MLXIPL | MLX interacting protein-like | Disease related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
MOCOS | Molybdenum cofactor sulfurase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
MROH2A | Maestro heat-like repeat family member 2A | | | | | | Tissue enhanced |
MYO1B | Myosin IB | | | | | | Tissue enhanced |
NEU4 | Sialidase 4 | Enzymes
| | | | | Tissue enhanced |
NPW | Neuropeptide W | Predicted secreted proteins
| | | | | Tissue enhanced |
NR0B2 | Nuclear receptor subfamily 0, group B, member 2 | Disease related genes Nuclear receptors Transcription factors
| | | | | Tissue enhanced |